Rapid detection of most frequent Slovenian germ-line mutations in BRCA1 gene using real-time PCR and melting curve analysis

Radiology and Oncology

Volumn 39, Issue 2, 2005, Pages

  Novaković, Srdjan ^a   Stegel, Vida ^a  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

Breast neoplasms genetics; Genes, BRCA1; Mutation; Polymerase chain reaction

Indexed keywords

BRCA1 PROTEIN; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 2A; CYCLIN DEPENDENT KINASE 4; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER SUSCEPTIBILITY; CDK4 GENE; CDKN2A GENE; COLORECTAL CANCER; CONTROLLED STUDY; DNA DETERMINATION; FAMILIAL CANCER; GENE; GENE MUTATION; GERM LINE; HUMAN; HUMAN CELL; MELANOMA; MELTING CURVE ANALYSIS; MELTING POINT; MISMATCH REPAIR; ONCOGENE; PERIPHERAL CIRCULATION; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS; SLOVENIA;

EID: 22644437807     PISSN: 13182099     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Roest PAM, Roberts RG, Sugino S, van Omen GJB, den Dunnen JT. Protein truncation test (PTT) for rapid detection of translation-terminating mutation. Hum Mol Genet 1993; 2: 1719-21.
2. Hayashi K, Wenz HM, Inazuka M, Tahira T, Sasaki T, Atha DH. SSCP analysis of point mutations by multicolor capillary electrophoresis. Methods Mol Biol 2001; 163: 109-26.
3. Myer RM, Lumelsky N, Lerman LS, Maniatis T. Detection of single base substitution in total genomic DNA. Nature 1985; 313: 495-8.
4. Foy CA, Parkers HC. Emerging homogeneous DNA-based technologies in the clinical laboratory. Clin Chem 2001; 47: 990-1000.
5. Wilhelm J, Pingout A. Real-time polymerase chain reaction. Chembiochem 2003; 4: 1120-8
6. Gerard P, Pindolia MS, Worsham MJ. A rapid and sensitive approach to mutation detection using real-time polymerase chain reaction and melting curve analyses, using BRCA1 as example. Mol Diagn 1999; 4: 241-6.
7. th edition. Philadelphia: Lippincott Williams & Wilkins; 2005.
8. King MC, Marks JH, Mandell JB. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003; 302: 643-6.
9. Loman N, Johannsson O, Kristoffersson U, Olsson H, Borg A. Family history of breast and ovarian cancers and BRCA2 and BRCA2 mutations in a population-based series of early-onset breast cancer. J Natl Cancer Inst 2001; 93: 1215-23.
10. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, Brody LC, Tucker MA. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997; 336: 1401-8.